Author-reported docking evaluation with category-specific mode.
These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.
Release 2026-09-30-e37e3ab1284d · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
1 evaluation · 11 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 12 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 11 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 6 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 1 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; intermediate column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort | 46.1% success_at_10 percent · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models % |
Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.
Not reported
Metadata review: source checked. Unreported conditions prevent automatic comparisons.
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
16 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.comparison.adaptation paper mode antibody Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.aggregation target success at capacity10 Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.budget Not reported Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | missing or unspecified No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.dataset_version BM5 Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.inputs BM5 component 3D structures Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.metric_implementation DockQ, version unextracted Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.population 26 Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.protocol_id ucc-docking-cluspro-bm5-2020-protocol-unbound-antibody-top10 Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.split unbound-antibody Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.origin author_reported Context-only references | Performance and its limits in rigid body protein-protein docking Table1 Unbound antibody row 1 Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
Stable ID: ucc-docking-cluspro-bm5-2020-eval-unbound-antibody-top10